213 related articles for article (PubMed ID: 31680263)
1. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
[TBL] [Abstract][Full Text] [Related]
2. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
3. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
Kennedy NA; Clark A; Walkden A; Chang JC; Fascí-Spurio F; Muscat M; Gordon BW; Kingstone K; Satsangi J; Arnott ID; Lees CW
J Crohns Colitis; 2015 Jan; 9(1):41-9. PubMed ID: 25135754
[TBL] [Abstract][Full Text] [Related]
6. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.
Dajti E; Frazzoni L; Iascone V; Secco M; Vestito A; Fuccio L; Eusebi LH; Fusaroli P; Rizzello F; Calabrese C; Gionchetti P; Bazzoli F; Zagari RM
Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1120-1131. PubMed ID: 37823411
[TBL] [Abstract][Full Text] [Related]
8. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
[TBL] [Abstract][Full Text] [Related]
9. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
[TBL] [Abstract][Full Text] [Related]
10. Faecal calprotectin in suspected paediatric inflammatory bowel disease.
Degraeuwe PL; Beld MP; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AG
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):339-46. PubMed ID: 25373864
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis.
Petryszyn P; Staniak A; Wolosianska A; Ekk-Cierniakowski P
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1306-1312. PubMed ID: 31464777
[TBL] [Abstract][Full Text] [Related]
12. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease.
Zhang W; Wong CH; Chavannes M; Mohammadi T; Rosenfeld G
BMJ Open; 2019 Apr; 9(4):e027043. PubMed ID: 30987989
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
Akobeng AK
Acta Paediatr; 2018 Nov; 107(11):2019-2023. PubMed ID: 29706011
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy.
Freeman K; Willis BH; Fraser H; Taylor-Phillips S; Clarke A
BMJ Open; 2019 Mar; 9(3):e027428. PubMed ID: 30852550
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care.
Pavlidis P; Chedgy FJ; Tibble JA
Scand J Gastroenterol; 2013 Sep; 48(9):1048-54. PubMed ID: 23883068
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]